Ginkgo Bioworks Holdings, Inc. (DNA)
9.73
-0.05
(-0.51%)
USD |
NYSE |
Dec 11, 13:31
Ginkgo Bioworks Holdings EPS Diluted (Quarterly): -1.452 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 1.432 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.76M |
| Revenue (Quarterly) | 38.84M |
| Total Expenses (Quarterly) | 119.59M |
| Enterprise Value | 544.78M |
| Gross Profit Margin (Quarterly) | 30.56% |
| Profit Margin (Quarterly) | -207.9% |
| Earnings Yield | -63.99% |
| Normalized Earnings Yield | -63.48 |